Octocog alfa (recombinant human coagulation factor VIII) [ADVATE]
060801
Approved mab completed
Quick answer
Octocog alfa (recombinant human coagulation factor VIII) [ADVATE] for Hemophilia A is a Approved program (mab) at Takeda with 2 ClinicalTrials.gov record(s).
Program details
- Company
- Takeda
- Indication
- Hemophilia A
- Phase
- Approved
- Modality
- mab
- Status
- completed